The Feasibility and Long-Term Outcomes of the Crossboss/Stingray for Treating Coronary Chronic Total Occlusions Lesions with Distal Diffuse Disease Landing Zone.
Sign Up to like & getrecommendations! Published in 2022 at "Reviews in cardiovascular medicine"
DOI: 10.31083/j.rcm2303113
Abstract: BACKGROUND The feasibility and long-term outcomes of the CrossBoss/Stingray for treating coronary chronic total occlusions (CTO) with distal diffuse disease landing zone remain unclear. METHODS Consecutive CTO patients with distal diffuse lesions that underwent percutaneous… read more here.
Keywords: stenosis group; stenosis; crossboss stingray; long term ... See more keywords